pCMV6-Entry IL36RN S113L Citations (1)

Originally described in: In Silico and In Vitro Analysis of IL36RN Alterations Reveals Critical Residues for the Function of the Interleukin-36 Receptor Complex.
Hassi NK, Weston T, Rinaldi G, Ng JC, Smahi A, Twelves S, Davan-Wetton C, Fakhreddine D, Fraternali F, Capon F J Invest Dermatol. 2023 Dec;143(12):2468-2475.e6. doi: 10.1016/j.jid.2023.06.191. Epub 2023 Jul 4. PubMed Journal

---

Articles Citing pCMV6-Entry IL36RN S113L

Articles

IL-36 signaling as a drug target in Crohn's disease patients with IL36RN mutations. Hecker J, Plattner C, Cancino CA, Loscher BS, Saurenbach J, Letizia M, Rieder D, Freise I, Koop K, Neufert C, Kunkel D, Al Khatim Z, Schaafs LA, Schutz A, Becker C, Atreya R, Trajanoski Z, Franke A, Sonnenberg E, Hegazy AN, Siegmund B, Weidinger C. EMBO Mol Med. 2025 Jul;17(7):1539-1555. doi: 10.1038/s44321-025-00245-z. Epub 2025 May 30. PubMed

If you have published an article using this material, please email us at to have your article added to this page.